Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors

Overview of attention for article published in Journal of Intensive Care, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,843 followers.

RT @accpemedprn: Our second article for Tuesday's #emedprnjc looks at safety of 4F-PCC for emergent reversal of Factor Xa Inhibitors - chec…

14 Sep 2018

Reply Repost Favourite

RT @accpemedprn: Our second article for Tuesday's #emedprnjc looks at safety of 4F-PCC for emergent reversal of Factor Xa Inhibitors - chec…

14 Sep 2018

Reply Repost Favourite

RT @accpemedprn: Our second article for Tuesday's #emedprnjc looks at safety of 4F-PCC for emergent reversal of Factor Xa Inhibitors - chec…

13 Sep 2018

Reply Repost Favourite

Our second article for Tuesday's #emedprnjc looks at safety of 4F-PCC for emergent reversal of Factor Xa Inhibitors - check it out here https://t.co/k43rwOLp4I

13 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.